Recruiting Pulmonary Hypertension Studies in Hackensack
About Pulmonary Hypertension Clinical Trials in Hackensack
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 16 pulmonary hypertension clinical trials recruiting participants in Hackensack, NJ. These studies are seeking a combined 2,401 participants. Research is being sponsored by AstraZeneca, Ascentage Pharma Group Inc., Novartis Pharmaceuticals and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Hackensack — FAQ
Are there pulmonary hypertension clinical trials in Hackensack?
Yes, there are 16 pulmonary hypertension clinical trials currently recruiting in Hackensack, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hackensack?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hackensack research site will contact you about next steps.
Are clinical trials in Hackensack free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hackensack studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 16 active trials in Hackensack are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 13, 2026 from ClinicalTrials.gov